Colgate Palmolive Co (CL) stock
CLNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3030% above fair value
$99.61−1.38 (-1.37%)
Close on Nov 17, 2026Market cap $79.18BP/E 39.1Yield 2.09%
Colgate Palmolive revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Colgate Palmolive's revenue for the twelve months ending Sep 30, 2026 was $21.28B, up 5.9% year over year. For fiscal 2025 it was $20.38B, up 1.4% from the year before. Over ten years it grew 2.4% a year on average. The highest annual figure on record is $20.38B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.38B | +1.4% |
| FY2024 | Dec 31, 2024 | $20.10B | +3.3% |
| FY2023 | Dec 31, 2023 | $19.46B | +8.3% |
| FY2022 | Dec 31, 2022 | $17.97B | +3.1% |
| FY2021 | Dec 31, 2021 | $17.42B | +5.8% |
| FY2020 | Dec 31, 2020 | $16.47B | +5.0% |
| FY2019 | Dec 31, 2019 | $15.69B | +1.0% |
| FY2018 | Dec 31, 2018 | $15.54B | +0.6% |
| FY2017 | Dec 31, 2017 | $15.45B | +1.7% |
| FY2016 | Dec 31, 2016 | $15.20B | -5.2% |
| FY2015 | Dec 31, 2015 | $16.03B | -7.2% |
| FY2014 | Dec 31, 2014 | $17.28B | -0.8% |
| FY2013 | Dec 31, 2013 | $17.42B | +2.0% |
| FY2012 | Dec 31, 2012 | $17.09B | +2.1% |
| FY2011 | Dec 31, 2011 | $16.73B | +7.5% |
| FY2010 | Dec 31, 2010 | $15.56B | +1.5% |
| FY2009 | Dec 31, 2009 | $15.33B | -0.0% |
| FY2008 | Dec 31, 2008 | $15.33B | +11.2% |
| FY2007 | Dec 31, 2007 | $13.79B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $5.37B | +4.6% |
| Q2 FY2026 | Jun 30, 2026 | $5.36B | +4.9% |
| Q1 FY2026 | Mar 31, 2026 | $5.32B | +8.4% |
| Q4 FY2025 | Dec 31, 2025 | $5.23B | +5.8% |
| Q3 FY2025 | Sep 30, 2025 | $5.13B | +1.9% |
| Q2 FY2025 | Jun 30, 2025 | $5.11B | +1.0% |
| Q1 FY2025 | Mar 31, 2025 | $4.91B | -3.0% |
| Q4 FY2024 | Dec 31, 2024 | $4.95B | -0.1% |
| Q3 FY2024 | Sep 30, 2024 | $5.03B | +2.4% |
| Q2 FY2024 | Jun 30, 2024 | $5.06B | +4.9% |
| Q1 FY2024 | Mar 31, 2024 | $5.07B | +6.2% |
| Q4 FY2023 | Dec 31, 2023 | $4.95B | +6.9% |
| Q3 FY2023 | Sep 30, 2023 | $4.92B | +10.3% |
| Q2 FY2023 | Jun 30, 2023 | $4.82B | +7.5% |
| Q1 FY2023 | Mar 31, 2023 | $4.77B | +8.4% |
| Q4 FY2022 | Dec 31, 2022 | $4.63B | +5.1% |
| Q3 FY2022 | Sep 30, 2022 | $4.46B | +0.9% |
| Q2 FY2022 | Jun 30, 2022 | $4.48B | +5.3% |
| Q1 FY2022 | Mar 31, 2022 | $4.40B | +1.3% |
| Q4 FY2021 | Dec 31, 2021 | $4.40B | +1.8% |
| Q3 FY2021 | Sep 30, 2021 | $4.41B | +6.3% |
| Q2 FY2021 | Jun 30, 2021 | $4.26B | +9.3% |
| Q1 FY2021 | Mar 31, 2021 | $4.34B | +6.0% |
| Q4 FY2020 | Dec 31, 2020 | $4.32B | +7.7% |
| Q3 FY2020 | Sep 30, 2020 | $4.15B | +5.7% |
| Q2 FY2020 | Jun 30, 2020 | $3.90B | +0.8% |
| Q1 FY2020 | Mar 31, 2020 | $4.10B | +5.5% |
| Q4 FY2019 | Dec 31, 2019 | $4.02B | +5.4% |
| Q3 FY2019 | Sep 30, 2019 | $3.93B | +2.2% |
| Q2 FY2019 | Jun 30, 2019 | $3.87B | -0.5% |
| Q1 FY2019 | Mar 31, 2019 | $3.88B | -2.9% |
| Q4 FY2018 | Dec 31, 2018 | $3.81B | -2.1% |
| Q3 FY2018 | Sep 30, 2018 | $3.85B | -3.2% |
| Q2 FY2018 | Jun 30, 2018 | $3.89B | +1.6% |
| Q1 FY2018 | Mar 31, 2018 | $4.00B | +6.4% |
| Q4 FY2017 | Dec 31, 2017 | $3.89B | +4.6% |
| Q3 FY2017 | Sep 30, 2017 | $3.97B | – |
| Q2 FY2017 | Jun 30, 2017 | $3.83B | – |
| Q1 FY2017 | Mar 31, 2017 | $3.76B | – |
| Q4 FY2016 | Dec 31, 2016 | $3.72B | – |
See a number that looks wrong?